Jaguar Health (JAGX) EBT Margin (2015 - 2026)
Jaguar Health's (JAGX) quarterly EBT Margin came in at 43.03% in Q1 2026, up 52162.0% year-on-year from N/an in Q1 2025, and up 106.0% on a QoQ basis from 716.94% in Q4 2025.
Jaguar Health (JAGX) EBT Margin (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of EBT Margin data on file, last reported at 43.03% in Q1 2026.
- On a quarterly basis, EBT Margin rose 52162.0% year-over-year to 43.03% in Q1 2026; TTM through Mar 2026 was 117.28%, a 23313.0% increase from a year earlier, with the FY2025 full-year figure at 469.09%, down 13330.0% from the prior year.
- EBT Margin for Q1 2026 stood at 43.03%, up from 716.94% in the prior quarter.
- Over the last five years, EBT Margin for JAGX reached as high as 43.03% in Q1 2026 and fell as low as 90820.0% in Q1 2022.
- Historically, EBT Margin has averaged 8773.98% across 5 years, with a median of 398.47% in 2024.
- Across the five-year window, EBT Margin tumbled 8982588 bps in 2022 and soared 6327111 bps in 2023, its largest moves.
- Year by year, EBT Margin stood at 25725.0% in 2022, then soared by 98 bps to 404.74% in 2023, then climbed by 28 bps to 291.65% in 2024, then slumped by 146 bps to 716.94% in 2025, then surged by 106 bps to 43.03% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 43.03% in Q1 2026, 716.94% in Q4 2025, and 312.94% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn | 17.13% |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn | 41.95% |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn | 23.05% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn | 34.77% |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn | 18.99% |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - | - |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn | 43.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.03% |
| Dec 31, 2025 | -716.94% |
| Sep 30, 2025 | -312.94% |
| Jun 30, 2025 | -354.48% |
| Mar 31, 2025 | -478.59% |
| Dec 31, 2024 | -291.65% |
| Sep 30, 2024 | -322.43% |
| Jun 30, 2024 | -353.84% |
| Mar 31, 2024 | -398.47% |
| Dec 31, 2023 | -404.74% |
| Sep 30, 2023 | -280.98% |
| Jun 30, 2023 | -467.87% |
| Mar 31, 2023 | -27,548.89% |
| Dec 31, 2022 | -25,725.00% |
| Sep 30, 2022 | -402.46% |
| Jun 30, 2022 | -321.47% |
| Mar 31, 2022 | -90,820.00% |
| Dec 31, 2021 | -688.37% |
| Sep 30, 2021 | -1,982.44% |
| Jun 30, 2021 | -3,715.30% |